“…Owing to their numerous advantages, Cu MOFs are suitable candidates for the development of nano-delivery platforms: I) they provide a unique broad-spectrum antibacterial effect ( Lee et al, 2021 ; Wang Z. et al, 2022 ); II) they possess the ability to stimulate endothelial cell proliferation and differentiation, thereby promoting angiogenesis by simulating hypoxia ( Dang et al, 2020 ); III) they possess an open skeleton framework and excellent chemical stability ( Liu et al, 2019 ); IV) they possess a unique near-infrared (NIR) absorption ability, which can be used to develop photo-thermal therapy (PTT) nano-drug system ( Weng et al, 2020 ; Wang L. et al, 2021 ; Geng et al, 2022 ); V) they have a favorable loading capacity and are a good choice for developing chemodynamic therapy (CDT) nanocarriers ( Hao et al, 2021b ). Recently, small-molecule drugs, such as chlorhexidine ( Soltani and Akhbari, 2022 ), DOX ( Gharehdaghi et al, 2021 ), 5-fluorouracil ( Liu W. et al, 2020 ), methotrexate ( Nezhad-Mokhtari et al, 2019 ), diclofenac sodium, chlorpromazine hydrochloride, amodiaquin dihydrochloride ( Liu et al, 2019 ), and ibuprofen ( Javanbakht et al, 2019 ), have been successfully loaded into nano-drug delivery systems through Cu MOFs. Enzymatically active molecules, such as horseradish peroxidase and glucose oxidase, can also be effectively loaded by Cu MOFs and exhibit superior stabilities than those in the free state ( Hao et al, 2021a ; Lin et al, 2021 ).…”